论文部分内容阅读
肺动脉高压常呈进展性发展并危及生命。目前单药治疗效果并不理想。联合治疗是有前途的治疗方法,并成为肺动脉高压药物治疗未来的发展方向。本文对联合药物治疗的现有循证医学证据做一综述。
Pulmonary hypertension is often progressive development and life-threatening. The current single-agent treatment is not ideal. Combination therapy is a promising treatment, and become the future development direction of pulmonary hypertension drug treatment. This article reviews the evidence-based medical evidence available for combination drug therapy.